Generieke Naam
|
Handelsmerknaam/
Alternatiewe naam
|
Uitdruksstelsel
|
Aanwysings
|
Vervaardiger
|
Ondernaveldigingsfase
|
Rekombinante menslike interferon α-2b-INTRON A
|
YM-14090, Viraferon, IntronA, Intron A, 甘乐能
|
Escherichia coli (E. coli)
|
Tumors, Ansteeklike siektes, Verdausstelsel siektes, bloedstelsel siektes
|
MSD, Merck, schering plough
|
Goedkeuring
|
Pegylated Interferon α-2b
|
PegIntron, 佩乐能, Redipen, Peg-Intron, Virtron, C-Pegferon, Cylatron
|
E. coli
|
Tumors, Ansteeklike siektes, Verdausstelsel siektes, bloedstelsel siektes
|
MSD, Merck, schering plough
|
Goedkeuring
|
Recombinant menslike interferon α-2a
|
ROFERON-A
|
E. coli
|
Tumor, Ansteeklike siektes, bloedstelsel siektes, Verdigestiestelsel siektes
|
Roche
|
Goedkeuring
|
Polyetylen glikol recombinant interferon α-2a
|
派罗欣, Pegasys, ペガシス
|
E. coli
|
Ansteeklike siektes, Verdigestiestelsel siektes, Immuunstelsel siektes, Tumor, bloedstelsel siektes, Urinestelsel siektes
|
Nektar Therapeutics, Roche, Aradigm, InterMune, Chugai Pharmaceutical Co., Ltd.
|
Goedkeuring
|
interferonα-1
|
Interferon alfacon-1, YM 643, IFN-Con1, Inferax, Advaferon, Infergen
|
E. coli
|
Tumor, Infektiuese siektes
|
Amgen, Astellas Pharma Inc, Takeda, Kadmon Pharmaceuticals, Chiesi Pharmaceutical (Shangai) Co., Ltd
|
Goedkeuring
|
Proliine interferon α-2b
|
Ropeginterferon alfa-2b-njft, P-1101, AOP-2014, Besremi, ベスレミ
|
E. coli
|
Infektiuese siektes, Tumor, bloedstelsel siektes, Verdigestiestelsel siektes
|
PharmaEssentia, AOP Orphan
|
Goedkeuring
|
Rekombinant menslike interferon α2b (Pseudomonas)
|
里亚美, 利分能
|
Pseudomonas
|
Tumor, Infektiuese siektes
|
HAPHARM GROUP CO.,LTD.
|
Goedkeuring
|
Rekombinante interferon α-2a
|
Interferon α-2a-Inmutag, Inferon, Inmutag, Inter 2A
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Biosidus
|
Goedkeuring
|
Rekombinante interferon α-2b
|
peginterferon alfa-2b-Bioferon, Citopheron, Ganapar, Zavinex, Inter 2B
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Biosidus
|
Goedkeuring
|
Polietilen glikol rekombinante interferon α-2b
|
peginterferon alfa-2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Biocad
|
Goedkeuring
|
Interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
BioGeneric Pharma SAE
|
Goedkeuring
|
interferon α-2a
|
INTEFEN-IFN
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Biolotus Biotech Ltda
|
Goedkeuring
|
interferon α-2a
|
BLAUFERON-A
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Blau Farmacêutica SA
|
Goedkeuring
|
interferon-α2
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
CJ CheilJedang Corp.
|
Goedkeuring
|
interferon α-2a biosimilars
|
r-hu-IFNa2
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Elea Spa
|
Goedkeuring
|
interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Fundação Oswaldo Cruz
|
Goedkeuring
|
interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Getz Pharma Research
|
Goedkeuring
|
Interferon α-2a
|
迪恩安
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Liaoning Satellite
|
Goedkeuring
|
Pegylated interferon α2a
|
Optipeg-A
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Incepta Pharmaceuticals Ltd.
|
Goedkeuring
|
interferonα-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Intas Biopharmaceuticals
|
Goedkeuring
|
Pegylated Interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Intas Biopharmaceuticals
|
Goedkeuring
|
interferonα-2b
|
Heberon Alfa R, Inrec
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Internasionale Sentrum vir Genetiese Ingenieurswese en Biotechnologie
|
Goedkeuring
|
interferonα-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Keepharma Ltd.
|
Goedkeuring
|
interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Laboratorio Varifarma SA
|
Goedkeuring
|
interferon α-2b
|
Lanstion
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Landsteiner Scientific SA de CV
|
Goedkeuring
|
Pegylated Interferon α-2b biosimilars
|
Pegstat
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Nanogen Pharmaceutical
|
Goedkeuring
|
interferon α
|
OPC-18, IFN-alpha, Alfaferone, Oif
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Otsuka Holdings Co., Ltd.
|
Goedkeuring
|
Rekombinant menslike interferon α
|
Interferon Alfa
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Reliance Life Sciences
|
Goedkeuring
|
interferon α-2b
|
ReliFeron
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Reliance Life Sciences
|
Goedkeuring
|
interferon α-2a
|
Reiferon
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Rhein-Minapharm
|
Goedkeuring
|
interferon α-2b
|
Kalferon
|
Wag opdate
|
Tumor, Infektiuese siektes
|
PT Kalbe Farma Tbk
|
Goedkeuring
|
interferon α-N3
|
interferon alfa-N3
|
NA, uitstrekking van leucosiete
|
Tumor, Infektiuese siektes
|
Stem Cell Innovations
|
Goedkeuring
|
interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Teva Pharmaceutical Industries Ltd
|
Goedkeuring
|
Pegylated interferon α2a
|
Pegaferon
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Panpharmaceuticals
|
Goedkeuring
|
Pegylated Interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Panpharmaceuticals
|
Goedkeuring
|
interferon α-2b
|
Altevir
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Pharmapark LLC
|
Goedkeuring
|
interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
PharmBiotek Navorsing en Produksie LLC
|
Goedkeuring
|
interferon α-2b
|
Alfarona, Alpharona, Alfaron
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Pharmaclon
|
Goedkeuring
|
interferon α-2a
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Pooyesh Darou Biopharmaceuticals
|
Goedkeuring
|
interferon α-2b
|
PDferon-B
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Pooyesh Darou Biopharmaceuticals
|
Goedkeuring
|
interferon α-2b
|
Urifron
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Probiomed SA de CV
|
Goedkeuring
|
interferon α
|
Leu-IFN, Multiferon
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Viragen, Inc.
|
Goedkeuring
|
interferon α-2b
|
VIPEG
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Virchow Group
|
Goedkeuring
|
interferon α-2b
|
Reaferon-EU-Lipint, Reaferon-EC-Lipint, Reaferon-ES-Lipint
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Vektor Medika
|
Goedkeuring
|
interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Zydus Lifesciences Ltd.
|
Goedkeuring
|
Pegylated Interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Zydus Lifesciences Ltd.
|
Goedkeuring
|
interferon α-2b
|
Intermax Alpha
|
Wag opdate
|
Tumor, Infektiuese siektes
|
LG Chem
|
Goedkeuring
|
interferon α-2b
|
rHuIFNa-2b, 安达芬
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Anhui Anke Biotechnology (Group) Co., Ltd
|
Goedkeuring
|
Rekombinante menslike interferon α-2b
|
interferon alpha 2b, Kain Yisheng
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Beijing Kawin Technology Share-Holding Co., Ltd.
|
Goedkeuring
|
CePEG-IFN
|
Cepeginterferon alfa-2b, Algeron, Pegylated menslike interferon A-2B, CePEG-IFN
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Biocad
|
Goedkeuring
|
interferon α
|
Interferon alpha vaginale, Interferon alpha vaginale, Opin
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Vitapharm Technology
|
Goedkeuring
|
Rekombinante menslike interferon α2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Yuance
|
Goedkeuring
|
Recombinante menslike interferon α2a gels
|
Recombinante interferon alpha-2a, 忆林, Yilin
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Changchun ChangSheng Gene Pharmaceutical Co., Ltd
|
Goedkeuring
|
Rekombinante menslike interferon α2b
|
lang lewe Fukan
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Changchun Instituut vir biologiese produkte
|
Goedkeuring
|
interferonα-2a
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Changchun Instituut vir biologiese produkte
|
Goedkeuring
|
Rekombinant menslike interferon α
|
Interferon Alfa
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Sumitomo Pharma
|
Goedkeuring
|
Rekombinante menslike interferon α2b
|
you Ni Long
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Hainan Unipul Pharmaceutical Co., Ltd
|
Goedkeuring
|
interferonα-2a
|
bell Fen
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Hainan Xinmingda Bio-Pharma
|
Goedkeuring
|
interferonα-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Furuibang Groep
|
Goedkeuring
|
Rekombinante menslike interferon α2b
|
you Jing'an
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Lee's Pharmaceutical
|
Goedkeuring
|
Recombinant menslike interferon α-2a
|
Interferon alfa 2a
|
Wag opdate
|
Tumor, Infektiuese siektes
|
3SBIO
|
Goedkeuring
|
Y-tipe Polietilen glikol rekombinante interferon α-2b
|
peggenbin
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Amoytop
|
Goedkeuring
|
Rekombinante menslike interferon α2b
|
wanfuyin
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Tenry
|
Goedkeuring
|
Rekombinant menslike interferon α2a
|
万复洛
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Tenry
|
Goedkeuring
|
Rekombinante menslike interferon α2b
|
辛复宁, 辛化诺
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Shanghai Huaxin Biotechnology Co., Ltd
|
Goedkeuring
|
Rekombinante menslike interferon α-2b
|
interferon alpha 2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Shanghai Wanxing
|
Goedkeuring
|
Recombinant menslike interferon α-2a
|
Interferon alfa 2a
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Shanghai Wanxing, Tenry
|
Goedkeuring
|
Rekombinante menslike interferon α-2b
|
Rekombinant menslike interferon alpha-2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Interlong
|
Goedkeuring
|
Rekombinante menslike interferon α-2b
|
anfu Long, Jie Fu
|
Wag opdate
|
Tumor, Infektiuese siektes
|
SINOBIOWAY Geneesmiddel
|
Goedkeuring
|
interferon α-2b
|
rHuIFNa-2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Changchun Heberbiological Technology Co., Ltd
|
Goedkeuring
|
interferon α-2a
|
intefin
|
Wag opdate
|
Tumor, Infektiuese siektes
|
3SBIO
|
Goedkeuring
|
Rekombinante menslike interferon α2b
|
lai Fu Long
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Beisheng Pharma Hansheng
|
Goedkeuring
|
Rekombinant menslike interferon α2a
|
aoping
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Wuhan weiao
|
Goedkeuring
|
Y tipe Polyetylen glikol rekombinante interferon α-2a
|
Y-vormige pegylasie interferon α-2a
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Amoytop
|
Fase II\/III
|
Polyetylen glikol rekombinante interferon α
|
Peginterferon alpha
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Europese Organisasie vir Navorsing en Behandeling van Kanker
|
Fase III
|
Interferon alpha-2b\/interferon gamma
|
Interferon-gamma\/interferon-alpha-2b, CIGB-128, CIGB-128-A
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Heber Biotec SA
|
Fase II
|
Recombinant menslike interferon α-2b inhaalmiddel -AP003
|
interferon alpha 2b inhalasie-AP003, AntiCovir, AP 003
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Altum Pharmaceuticals, BetterLife Pharma
|
Fase II
|
Rekombinant menslike interferon α
|
Interferon Alfa
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Amarillo Biosciences
|
Fase II
|
Pegylated interferon alpha-2a
|
PegIFN-alpha2a
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Janssen Research & Development LLC
|
Fase II
|
IFNα-Kinoid
|
Menslike IFN-α2b gekoppel aan 'n T-huldragaar eiwit, CKD971, SS-002, SS002, SS 002
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Centurion Pharma, Chong Kun Dang, Neovacs, Biosense Global
|
Fase II
|
interferonα1b
|
Peginterferon α1b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Shanghai Institute of Biological Products Co., Ltd
|
Fase II
|
interferonα-N1
|
Interferon alfa-N1
|
Wag opdate
|
Tumor, Infektiuese siektes
|
GSK
|
Fase II
|
Polietilen glikol rekombinante interferon α-2b
|
peginterferon alfa-2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Anhui Anke Biotechnology (Group) Co., Ltd
|
Fase II
|
interferonα-2b
|
Hanferon, HL-031
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Nautilus Biotech
|
Fase II
|
Recombinant human interferon α-2b spuit
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Anhui Anke Biotechnology (Group) Co., Ltd
|
Fase II
|
Rekombinante menslike interferon α-2b
|
interferon alpha 2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Hanall
|
Fase I\/II
|
MSC-IFN α
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Wuxi Huatai Innovative Pharmaceutical
|
Fase I\/II
|
SAR441000
|
n mRNA mengsel wat IL-12sc, interferon alpha2b, GM-CSF en IL-15 kodeer
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Sanofi, BioNTech
|
Fase I
|
Rekombinante menslike serumalbumien en interferon α-2b-fusieprotein
|
Rekombinante menslike serumalbumien en interferon α-2b-kangbao groep
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Shanxi Kangbao
|
Fase I
|
Rekombinante menslike interferon α-2b
|
interferon alpha 2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Kexing Biopharma
|
Fase I
|
Rekombinante menslike serumalbumien interferon α2a fusesieprotein
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Qilu Pharmaceutical
|
Fase I
|
Rekombinante menslike serumalbumien interferon α2a fusesieprotein
|
rHSA-IFN alpha-2a, SFR-9213
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Fortunerock (China)
|
Fase I
|
Rekombinante menslike serumalbumien en interferon α-2b-fusieprotein
|
Rekombinante menslike serumalbumien en interferon α-2b-kangbao groep
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Anhui Anke Biotechnology (Group) Co., Ltd
|
Voor-klinies
|
Polietilen glikol rekombinante interferon α-2b
|
peginterferon alfa-2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
SL Pharm
|
Voor-klinies
|
AL-683
|
Hiper-glikoseleerde IFN Alfacon-1
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Alios BioPharma
|
Voor-klinies
|
AL-624
|
Hiper-glikoseleerde IFN Alfacon-1
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Johnson Johnson, Alios BioPharma
|
Voor-klinies
|
Polietilen glikol rekombinante interferon α-2b
|
peginterferon alfa-2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Shanghai Meiye Biotechnology
|
Voor-klinies
|
Rekombinant menslike interferon α
|
Interferon Alfa
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Shanghai GeneCore BioTechnologies
|
Voor-klinies
|
Rekombinante menslike serumalbumien en interferon α-2b-fusieprotein
|
Rekombinante menslike serumalbumien en interferon α-2b-kangbao groep
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Wolwo Pharma
|
Voor-klinies
|
Rekombinante menslike interferon α-2a-Tuimelvaatspesifieke bindingpeptide NGR fusionsprotein
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
JIUZHOU Groep
|
Voor-klinies
|
Recombinant human interferon α-2b spuit
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Amoytop
|
Voor-klinies
|
Rekombinant menslike interferon α
|
Interferon Alfa
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Ainos, Inc.
|
Voor-klinies
|
Tipe Q101 Polietilen glikol rekombinante interferon α-2a
|
Q101 pegylasie interferon α-2a, PEG-IFN-α-2a, Q-101
|
Wag opdate
|
Tumor, Infektiuese siektes
|
CSPC Pharma
|
Wag opdate
|
Pegylated Interferon α-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Pharmstandard PJSC
|
Wag opdate
|
Polyetylen glikol recombinant interferon α-2a
|
Peginterferon Alfa-2a
|
Wag opdate
|
Tumor, Infektiuese siektes
|
CHITAI TIANQING
|
Wag opdate
|
Polietilen glikol rekombinante interferon α-2b
|
peginterferon alfa-2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Changchun Heberbiological Technology Co., Ltd
|
Wag opdate
|
Tipe Q101 Polietilen glikol rekombinante interferon α-2a
|
Q101 pegylasie interferon α-2a, PEG-IFN-α-2a, Q-101
|
Wag opdate
|
Tumor, Infektiuese siektes
|
CSPC Pharma
|
Wag opdate
|
Polietilen glikol rekombinante interferon α-2b
|
peginterferon alfa-2b
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Amoytop
|
Wag opdate
|
Albumin interferon α
|
Albumin-Interferon Alfa, alb-IFN, Albinterferon
|
Wag opdate
|
Tumor, Infektiuese siektes
|
GSK, Novartis, Human Genome Sciences
|
Wag opdate
|
Rekombinante menslike serumalbumien en interferon α-2b-fusieprotein
|
Rekombinante menslike serumalbumien en interferon α-2b-kangbao groep
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Hangzhou Jiuyuan Gene Engineering Co., Ltd
|
Wag opdate
|
interferonα-2b
|
Wag opdate
|
Wag opdate
|
Tumor, Infektiuese siektes
|
AXXO Im- und Export GmbH
|
Wag opdate
|
Recombinant menslike interferon α-2a
|
Interferon alfa 2a
|
Wag opdate
|
Tumor, Infektiuese siektes
|
BioPartners GmbH
|
Wag opdate
|
interferonα-2b
|
AP-001
|
Wag opdate
|
Tumor, Infektiuese siektes
|
Helix BioPharma Corp.
|
Wag opdate
|
rekombinante konsensus interferon α
|
Rekombinante konsensus interferon α
|
Wag opdate
|
Tumor, Infektiuese siektes
|
SL Pharm
|
Wag opdate
|